Gene handles health industry mergers and acquisitions, securities offerings and joint ventures. He also assists clients with payment issues involving Medicare and Medicaid; physician services; and drugs, devices and durable medical equipment. Gene also focuses on matters involving federal and state fraud and abuse prohibitions, as well as on health care policy and legislation.

Gene has extensive experience in reviewing business arrangements and transactions among health industry participants for compliance with federal and state fraud and abuse provisions, fee-splitting and corporate practice of medicine prohibitions, and other statutory and regulatory restrictions. His representative engagements range from drafting individual contracts to comprehensive due diligence reviews of entire health care systems in connection with acquisitions, private placements or public debt offerings.

Gene drafts and provides strategic advice pertaining to:

• Hospital and other provider contracts
• Physician recruitment arrangements
• Physician office leases
• Patient transfer and referral agreements
• Provider and non-provider joint ventures
• Exclusive hospital-based physician group contracts
• A wide variety of other health industry business arrangements.

He also has substantial experience in representing biotechnology companies regarding coverage of, and payment for, new medical technologies by government and private health insurance programs.

Gene served on the advisory board of BNA’s Health Care Fraud Report, a national biweekly publication covering health care fraud and abuse issues affecting federal and state health care programs, managed care organizations and the private insurance industry. He also developed and maintains Compliance Land, a public website providing free access to a wealth of statutory and regulatory fraud and abuse resources, including full-text searching of the Office of Inspector General’s advisory opinions.